New England Journal of Medicine
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
New England Journal of Medicine
May 13, 2024, 08:08 |
Blog
Monica Bertagnolli: Fascinating research I recently read about CAR-T therapy
Monica Bertagnolli shared a post on LinkedIn: ''Fascinating research I recently read about in the New…
May 1, 2024, 17:02 |
Opinion
Uri Ilan: This isn't the first time we've seen AI in the exam room
Uri Ilan, Researcher PhD Student, Coordinator of the International Leukemia/Lymphoma Target Board, shared a post…
May 1, 2024, 10:59 |
Blog
Michael Kupferman: Madappa Kundranda sat down with Arizona PBS Horizon to discuss a potential new way to screen for colorectal cancer
Michael Kupferman, Senior Vice President at Banner Health, shared a post on LinkedIn: "Banner MD…
Apr 28, 2024, 14:27 |
Blog
Michael D. : Meet the Master-Hands of Medicine
Michael D., Support Analyst at Sarah Cannon Research Institute, shared a post by Vivek Subbiah…
Apr 25, 2024, 20:18 |
Positive
Vivek Subbiah: HUGE MILESTONE in all of medicine and a huge win for patients and families with sickle cell disease and β-Thalassemia
Quoting Vivek Subbiah's post on X/Twitter: "Hot off the press! HUGE MILESTONE in all of…
Apr 9, 2024, 09:03 |
Insight
Giannis Mountzios: The value of post-marketing pragmatic re-assessment of new TKIs in NSCLC
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
Apr 8, 2024, 14:54 |
Insight
Piotr Wysocki: New data solidify the idea of omitting axillary dissection in breast cancer patients with clinically N0 disease and macrometastases in 1-2 sentinel LN
Piotr Wysocki, Head of the Clinical Oncology Department at Jagiellonian University Hospital, shared on LinkedIn:…
Apr 7, 2024, 03:41 |
Insight
Sarah Sammons: How do we tailor adjuvant therapy without axillary dissection?
Sarah Sammons, Medical Oncologist at Dana-Farber’s Breast Oncology Center, recently shared a post by Massimo…
Apr 5, 2024, 18:16 |
Insight
Timothée Olivier: NATALEE trial, adjuvant ribociclib 21 days/28 for… 3 years! Cost alert!!
Timothée Olivier, Medical Oncologist at HUG - Geneva University Hospitals, shared a post by the…
Feb 21, 2024, 18:18 |
Insight
Vivek Subbiah: As of December 31, 2023, the FDA had become aware of 22 cases of T-cell cancers that occurred after treatment with CAR-T products
Vivek Subbiah shared on LinkedIn: "Perspective article on 'Secondary Cancers after Chimeric Antigen Receptor T-Cell…
1
2
All:
14
Posts:
1 - 10
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Neuroendocrine tumors - newly updated AJCC guidelines
5 min Sarcoma Talk with Shushan Hovsepyan and Andrea Ferrari
Facebook
RSS Feed
Twitter
Linkedin
Youtube